|
Type of surgery
|
Number of procedures (n = 4001)
|
Median age- (25th-75th percentile)
|
Female gender - n (%)
|
Mortality – n (%)
|
All VTE – n (%; 95% CI)
|
PE – n (%; 95% CI)
|
DVT – n (%; 95% CI)
|
|---|
|
Total hip replacement
| | | | | | | |
|
-Degenerative hip disorder
|
1691
|
71.1 (62–78)
|
1101 (65.1)
|
10 (0.6; 0.3-1.1)
|
40 (2.4; 1.7-3.2)
|
14 (0.8; 0.5-1.4)
|
28 (1.7; 1.1-2.4)
|
|
- Fracture
|
348
|
78.5 (73–83)
|
272 (78.2)
|
9 (2.6; 1.3-5.0)
|
10 (2.9; 1.5-5.3)
|
3 (0.9; 0.3-2.7)
|
7 (2.0; 1.0-4.2)
|
|
- Fracture sequelae
|
522
|
77.9 (70–84)
|
392 (75.1)
|
13 (2.5; 1.4-4.3)
|
14 (2.7; 1.6-4.5)
|
6 (1.2; 0.5-2.6)
|
8 (1.5; 0.8-3.1)
|
|
Hemiarthroplasty
| | | | | | | |
|
- hip fracture
|
743
|
84.9 (80–89)
|
565 (76.0)
|
71 (9.6; 7.6-12.1)
|
7 (0.9; 0.4-2.0)
|
6 (0.8; 0.4-1.8)
|
1 (0.1; 0.02-1.0)
|
|
- Fracture sequelae
|
239
|
84.9 (81–90)
|
192 (80.3)
|
15 (6.3; 3.8-10.4)
|
3 (1.3; 0.4-3.9)
|
0
|
3 (1.3; 0.4-3.9)
|
|
Hip prosthesis revision
|
429
|
74.8 (64–82)
|
251 (58.5)
|
3 (0.7; 0.2-2.2)
|
5 (1.2; 0.5-2.8)
|
0
|
5 (1.2; 0.5-2.8)
|
|
Hip replacement - malignancy
|
29
|
64.3 (58–78)
|
21 (72.4)
|
1 (3.4; 0.5-24.5)
|
1 (3.4; 0.5-24.5)
|
0
|
1 (3.4; 0.5-24.5)
|
- Thromboprophylaxis was used for 7 to 10 days.
- Fracture sequelae = osteonecrosis of the femoral head or non-union and or implant failure after hip fracture surgery.
